Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
CAR-TCR Global 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Trial Updates
1:57
MOMENTUM: ARU-1801 in sickle cell disease
Will Chou
• 26 Jan 2022
2:23
DSG3-CAART: A novel CAAR T-cell therapy in pemphigus vulgaris
Samik Basu
• 26 Jan 2022
1:57
jCell: allogeneic cell therapy for retinitis pigmentosa
Gil Carrasquinho
• 2 Jul 2021
3:47
RP-L301 lentiviral gene therapy for PKD
Jose-Luis López-Lorenzo
• 15 Nov 2021
7:24
An update on the Phase I trial evaluating RP-L301 in PKD
Jose-Luis López-Lorenzo
• 15 Nov 2021
6:19
LYS-GM101 AAV gene therapy for GM1 gangliosidosis
Michael Hocquemiller
• 15 Nov 2021
3:42
GNT0003: AAV gene therapy for Crigler-Najjar syndrome
Lorenzo D'Antiga
• 18 Nov 2021
4:31
The safety of AVR-RD-01 gene therapy for Fabry disease
Mark Thomas
• 29 Oct 2021
2:38
LYS-SAF302 AAV gene therapy for MPS IIIA
Michael Hocquemiller
• 15 Nov 2021
1:16
Overcoming immunogenicity of gene therapies
Timothy Miller
• 18 Nov 2021
0:59
RESKUE: AAV-based gene therapy for Krabbe disease
Timothy Miller
• 18 Nov 2021
3:59
ATA3219, ATA3271 & ATA188: T-Cell immunotherapy products in development
Pascal Touchon
• 22 Oct 2021
2:03
AAV-based gene therapy for X-linked retinitis pigmentosa
Sue Washer
• 22 Oct 2021
2:12
Treating achromatopsia with AAV-based gene therapy
Sue Washer
• 22 Oct 2021
1:52
Optogenetics in advanced retinitis pigmentosa
Sue Washer
• 22 Oct 2021
2:40
LUMEVOQ gene therapy for LHON
Magali Taiel
• 6 Oct 2021
1
2
3
Next
